-
effectivehealthcare.ahrq.gov/sites/default/files/goldstrom.pdf
May 29, 2025 - SAMHSA
INNOVATIONS CONFERENCE -- SAMHSA
SPEAKER: INGRID GOLDSTROM,
DIRECTOR OF THE EVALUATION OF CHILDREN’S MENTAL HEALTH INTIATIVE
(CMHI)
SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION (SAMHSA)
GOLDSTROM: So today I’ll be speaking about engaging mental health
consu…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbi-protocol.pdf
August 09, 2021 - facilitate data extraction.
9
Assessment of the Risk of Bias of Individual Studies
We will evaluate … We will evaluate heterogeneity between studies using I2 indicator. … patients vs surrogates);
consistency of results (based on qualitative and statistical approaches to evaluate … We will use this information to evaluate applicability of the
evidence to real-world clinical practice
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_disposition-comments.pdf
August 23, 2012 - The clearly defined key questions and
outlined requirements for a study to evaluate those key
questions … It is disappointing that
this report − that was intended to organize knowledge and
evaluate evidence … As mentioned above, the purpose of this comparative
effectiveness review was not to evaluate the clinical
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
January 07, 2013 - Our task
for this systematic review was to
evaluate treatments used specifically
for unexplained or … It
was not in the scope of this report to
evaluate diagnosis or treatment for
other less common causes … To that end, the intent of
this report was to evaluate literature
looking at nonspecific therapies … and
their potential usefulness in patients
who cannot be easily diagnosed or
treated and to evaluate … We have reviewed these
exclusions to evaluate whether this
was an appropriate determination and
have
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-nomination_methods.pdf
November 01, 2012 - Some nominations to the EHC Program lack sufficient information to
evaluate the topic against EHC Program … such cases, we refer to
an established checklist for the minimum amount of information needed to evaluate … example, a nomination on physical therapy for acute ambulatory conditions
was too broad to develop or evaluate … Feasibility scan–a brief search for primary studies to evaluate the sufficiency of available
evidence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-education-protocol.pdf
January 01, 2018 - Notes will be reviewed and discussed by the investigators
to evaluate how KI input provides insight
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-272-genitourinary-syndrome-executive-summary.pdf
July 01, 2024 - Harms reporting (KQ3) was limited, in part, by studies not being sufficiently powered
to evaluate infrequent
-
effectivehealthcare.ahrq.gov/sites/default/files/use_of_handheld_ebell_presentation.pdf
January 01, 2009 - Ebell_Presentation_REVISED_FINAL
Source:
Eisenberg
Center
Conference
Series
2009,
Translating
Information
Into
Action:
Improving
Quality
of
Care
Through
Interactive
Media,
Effective
Health
Care
Program
Web
site
(http://www.effectivehealt…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
February 26, 2013 - 74 line 17: Suggest adding a statement stating that FFR
and IVIS are complementary modalities that evaluate … eligibility criteria
because this study combined the FFR-guided
and angiography-guided stenting groups to
evaluate … Jude Medical
Key Question 3 The draft report indicates that there is insufficient evidence to
evaluate … decision making to determine which lesions require
intervention prior to PCI, FFR can also be used to evaluate
-
effectivehealthcare.ahrq.gov/products/global-health-evidence-evaluation-framework/white-paper
-
effectivehealthcare.ahrq.gov/products/dietary-protein-intake/protocol
-
effectivehealthcare.ahrq.gov/products/mental-health-apps/report
-
effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - Evidence was insufficient
to evaluate within-class intervention comparisons. … Other than funding source, we were able only to evaluate
potential differences between Asian and non-Asian … Larger RCTs should evaluate differences in treatment
and adverse event effects in relevant subgroups … that RCTs will focus on these rarer and higher-
risk factors, it is more important for researchers to evaluate … for most outcomes of interest, we were able
to construct network meta-analyses (to simultaneously
evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - Evidence was insufficient
to evaluate within-class intervention comparisons. … Other than funding source, we were able only to evaluate
potential differences between Asian and non-Asian … Larger RCTs should evaluate differences in treatment
and adverse event effects in relevant subgroups … that RCTs will focus on these rarer and higher-
risk factors, it is more important for researchers to evaluate … for most outcomes of interest, we were able
to construct network meta-analyses (to simultaneously
evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
April 01, 2013 - The
first was to evaluate the comparative effectiveness of replacing or supplementing existing testing … The second aim of the review (Key Question 3) was to evaluate the comparative
effectiveness of replacing … The
first was to evaluate the comparative effectiveness of replacing or supplementing existing testing … 2
The second aim of the review was to evaluate the comparative effectiveness of replacing or
supplementing … methods report authored by the RTI-UNC EPC on behalf of AHRQ.11 The
following criteria were used to evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - This review will not include studies that evaluate the effectiveness
of preoperative or adjunctive interventions … Assessment of Methodological Risk of Bias
We will evaluate the methodologic risk of bias of individual … We may include in the analysis high of risk of bias studies that have a
large sample size or that evaluate … www.effectivehealthcare.ahrq.gov
Published online: March 1, 2016
12
Subgroup analysis may be used to evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
January 01, 2009 - Finally, evaluate the prevalence of the disease in diagnostic test studies. … In the fourth example, trials are conducted to evaluate the benefits and harms of carotid endarterectomy … For the comparator, the researcher first needs to evaluate the medication dose, schedule, and duration … For outcomes, the researcher needs to evaluate the outcomes and how they were defined.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
March 13, 2012 - We will design the data abstraction forms for this project to collect data required to
evaluate the … We will evaluate the quality of individual studies using the approach
described in AHRQ’s General Methods … To
evaluate methodological quality, we will apply criteria for each study type derived
from core elements … We will use these data to evaluate the applicability to clinical practice, paying special
attention
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - For example,
to evaluate the comparative effectiveness of a
multivisit behavioral intervention for … As noted
in the statin example above, the exposure time
window to evaluate the effectiveness of statins … time window is arbitrary or limited by
data, sensitivity analyses should be performed in
order to evaluate … exposure status of individuals cannot be
ascertained in the data being used in the analysis,
and should evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
January 01, 2009 - Finally, evaluate the prevalence of the disease in diagnostic test studies. … In the fourth example, trials are conducted to evaluate the benefits and harms of carotid endarterectomy … For the comparator, the researcher first needs to evaluate the medication dose, schedule, and duration … For outcomes, the researcher needs to evaluate the outcomes and how they were defined.